Pharmaceutical Intermediates Methyl 2-Aminothiazole-4-Carboxylate Cas No: 118452-04-3

Pharmaceutical Intermediates Methyl 2-Aminothiazole-4-Carboxylate Cas No: 118452-04-3


    • Product Name Pharmaceutical Intermediates Methyl 2-Aminothiazole-4-Carboxylate Cas No: 118452-04-3
    • Alias Methyl 2-aminothiazole-4-carboxylate
    • Einecs 629-888-9
    • Mininmum Order 1 Kilogram
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    897346

    Cas No 118452-04-3
    Molecular Formula C5H6N2O2S
    Molecular Weight 158.18 g/mol
    Appearance Typically a solid (color may vary, often white to off - white)
    Melting Point Data specific to this compound needed (usually determined experimentally)
    Boiling Point Data specific to this compound needed (usually determined experimentally)
    Solubility Solubility characteristics depend on solvents; may have limited solubility in water, better in some organic solvents
    Purity Can be found in different purity levels, often 95%+ for pharmaceutical intermediate use
    Stability Should be stored properly to maintain stability, may be sensitive to heat, light and moisture

    As an accredited Pharmaceutical Intermediates Methyl 2-Aminothiazole-4-Carboxylate Cas No: 118452-04-3 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of Methyl 2 - Aminothiazole - 4 - Carboxylate in sealed chemical - grade packaging.
    Shipping **Shipping of Pharmaceutical Intermediate Methyl 2 - Aminothiazole - 4 - Carboxylate (CAS No: 118452 - 04 - 3)** This chemical is shipped in well - sealed, corrosion - resistant containers. Compliance with all relevant chemical transportation regulations, ensuring safety during transit to safeguard both handlers and the environment.
    Storage Store Pharmaceutical Intermediates Methyl 2 - Aminothiazole - 4 - Carboxylate (Cas No: 118452 - 04 - 3) in a cool, dry, well - ventilated area. Keep it away from heat sources, ignition sources, and incompatible substances. Store in a tightly - sealed container to prevent moisture absorption and contamination, ensuring its stability and quality.
    Free Quote

    Competitive Pharmaceutical Intermediates Methyl 2-Aminothiazole-4-Carboxylate Cas No: 118452-04-3 prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introduction of the compound into a synthetic sequence generally occurs at the stage where the thiazole ring is fully assembled yet requires further functionalization. Methyl 2-aminothiazole-4-carboxylate (CAS 118452-04-3), a heterocyclic building block with the molecular formula C₅H₆N₂O₂S and a relative molecular mass of 158.18 g mol⁻¹, serves as a masked 2-aminothiazole-4-carboxylic acid equivalent. The product is supplied as an off-white to pale yellow crystalline powder, typically with a melting range of 165–169 °C and a chromatographic purity exceeding 99.0% by HPLC (area normalization, detection at 254 nm). The ester group permits selective amidation or hydrolysis under controlled conditions, while the primary amine at position 2 can be diazotized, acylated, or converted to a sulfonamide without disturbing the carbomethoxy function. These orthogonal reactivities make the material a strategic intermediate for cephalosporin side-chain elaboration and for constructing fused pyrimidine systems found in kinase inhibitor scaffolds.

    Purity Specifications and Trace Impurity Profiling

    Routine release testing demands adherence to internal limits harmonized with ICH Q3A. A representative certificate of analysis records a loss on drying value not exceeding 0.5% (determined at 105 °C for 2 hours) and a sulphated ash content below 0.1%. The area percentage of any single unspecified impurity is restricted to ≤0.15%. The manufacturing process, which typically closes the thiazole ring from ethyl bromopyruvate and thiourea followed by esterification, leaves behind traces of the regioisomer methyl 2-aminothiazole-5-carboxylate and the dechlorinated by-product when chloroacetyl derivatives are employed. The 5-carboxylate isomer is resolved under reversed-phase conditions (C18 column, 250 × 4.6 mm, 5 µm; mobile phase: acetonitrile/0.1% trifluoroacetic acid gradient) with a relative retention time of 1.3 against the main peak. Residual solvents are quantified by headspace GC‑FID; batch records indicate methanol levels consistently below 500 ppm and tetrahydrofuran below 200 ppm, aligning with Ph. Eur. 5.4 limits for Class 2 solvents.

    Stability studies conducted at 25 °C/60% RH over 36 months reveal no significant alteration in chromatographic purity when the container closure remains intact. Once opened, re-test intervals are recommended at 12 months if stored under nitrogen. The amino group is susceptible to slow oxidation, generating a faint yellow discoloration that correlates with a build‑up of the nitroso dimer, detectable at RRT 2.1. For that reason, bulk deliveries destined for multi‑step campaigns in non‑dedicated facilities are accompanied by an oxygen content limit in the headspace: < 1.5% v/v.

    How Does Methyl Ester Reactivity Compare to Ethyl and tert-Butyl Analogues?

    The methylation state exerts a measurable influence on both the activation energy of ammonolysis and the susceptibility to base‑catalysed hydrolysis. Comparative kinetic data acquired in methanol‑water at 40 °C with 0.1 M sodium hydroxide demonstrate that the methyl ester (second‑order rate constant k₂ ≈ 2.8 × 10⁻³ L mol⁻¹ s⁻¹) undergoes hydrolysis approximately 1.7‑fold faster than the ethyl congener (CAS 7210-75-3). The tert‑butyl ester, by contrast, survives the same conditions with less than 5% conversion after 6 hours. This graduation in reactivity is exploited when a sequence demands transient protection of the carboxyl group: the methyl ester withstands acylation of the 2‑amino group with acetyl chloride in dichloromethane at 0–5 °C provided the reaction is quenched within 90 minutes, whereas the ethyl analogue tolerates extended stirring for up to 4 hours without detectable transesterification. In practice, the methyl derivative is chosen when the subsequent step is a direct ammonolysis to the primary amide under mild thermolytic conditions—heating with 7 N ammonia in methanol at 55 °C in a sealed vessel achieves complete conversion within 8 hours—or when the goal is a one‑pot saponification–coupling sequence using a water‑soluble carbodiimide.

    Physicochemical and Handling Comparison of 2-Aminothiazole-4-carboxylate Esters
    ParameterMethyl EsterEthyl Estertert-Butyl Ester
    CAS Number118452-04-37210-75-3216959-62-9
    Melting Range (°C)165–169127–131142–146 (dec.)
    Solubility in Tetrahydrofuran at 25 °C (mg/mL)>100>100>100
    Hydrolytic Stability in pH 10 Buffer (t½, h)4.27.1>72
    Preferred ApplicationDirect amidation to carboxamideTransesterification with higher alcoholsSolid‑phase peptide coupling on resin
    Typical Residual Solvent ProfileMethanol <500 ppmEthanol <500 ppmMTBE <200 ppm

    When Residual Moisture Exceeds 0.5% in Downstream Amidation

    Plant‑scale campaigns generating the free thiazolocarboxamide for cephalosporin C‑series antibiotics have identified moisture as the dominant process variable affecting yield robustness. The amidation of the methyl ester with concentrated aqueous ammonia (28–30% w/w NH₃) proceeds through a tetrahedral intermediate whose collapse is retarded if adventitious water drives the equilibrium back toward the carboxylate. In a 500‑L glass‑lined reactor operating at a jacket temperature of 50 °C, a pre‑drying step under vacuum (5–10 mbar) for 4 hours with nitrogen bleed reduced the Karl Fischer water content of the ester charge from 0.8% to 0.2%, lifting the isolated yield of the carboxamide from 78% to 91% across three consecutive batches. The pre‑drying is executed directly in the reactor vessel, bypassing dedicated tray dryers, provided the vessel’s heating jacket can maintain a wall temperature of 60 °C without scorching the powder. Facilities lacking vacuum capability have adopted azeotropic drying with toluene; however, residual toluene must be reduced to <890 ppm to avoid failure under ICH Q3C Option 2 limits, requiring an additional solvent‑exchange distillation with methanol.

    An additional incompatibility observed during scale‑up involves co‑solvent selection for the amidation step. When dimethyl sulfoxide is used as a co‑solvent to homogenize the mixture, the amine’s nucleophilicity is attenuated, and the reaction stalls at 60–70% conversion. Switching to N‑methyl‑2‑pyrrolidone, despite its higher boiling point, restores the rate because its aprotic nature does not compete for hydrogen‑bonding with the ammonia nucleophile, yet N‑methyl‑2‑pyrrolidone must be stripped to <530 ppm to comply with the Permitted Daily Exposure of 5.3 mg/day in the finished pharmaceutical.

    Acylation of the 2‑amino group with 4‑chlorobutyryl chloride in acetone at −10 °C in the presence of potassium carbonate presents a competing reaction pathway: ring chlorination at the thiazole C‑5 position. Process analytical technology (ReactIR) monitoring of the carbonyl stretching frequency at 1720 cm⁻¹ distinguishes O‑acylation from N‑acylation, but the appearance of a peak at 680 cm⁻¹ (C‑Cl stretch) signals the onset of electrophilic aromatic substitution on the thiazole ring. Maintaining the pH of the aqueous bicarbonate scrub at 8.0–8.3 suppresses this side reaction to <1%.

    Differences from related intermediates such as 2‑aminothiazole‑4‑carboxylic acid hydrochloride (CAS 105337-56-0) are substantial when considering direct coupling in peptide‑like bond formations. The free acid salt demands activation with carbodiimide/hydroxybenzotriazole systems, introducing a hydration risk and additional unit operations for the removal of dicyclohexylurea. The methyl ester bypasses the activation step entirely when the target is the carboxamide, and its higher solubility in chlorinated solvents (dichloromethane solubility >50 mg/mL) facilitates homogeneous reactions with lipophilic acid chlorides. In applications where the carboxylic acid is ultimately required, the methyl ester is hydrolysed with lithium hydroxide in tetrahydrofuran/water (3:1) at 0 °C; this protocol avoids the decarboxylation that plagues the free acid at temperatures above 40 °C and yields the lithium carboxylate directly, which can be carried into amidation without isolation.

    What Analytical Markers Differentiate This Ester from the 5‑Carboxylate Isomer in Compendial Methods?

    European Pharmacopoeia monograph 01/2008:1487 for related cephalosporin precursors defines a system suitability requirement based on the resolution between the 4‑ and 5‑carboxylate regioisomers. For methyl 2‑aminothiazole‑4‑carboxylate, a dedicated HPLC procedure employing a phenyl‑hexyl stationary phase (150 × 4.6 mm, 3 µm) with an isocratic mobile phase of methanol/ammonium formate buffer pH 4.5 (30:70) yields a resolution factor Rs ≥3.0 between the 4‑ and 5‑substituted isomers. The 5‑carboxylate isomer displays a bathochromic shift in its UV spectrum, with λmax at 288 nm versus 274 nm for the 4‑carboxylate, offering an orthogonal detection method. For rapid in‑process control, 1H NMR (DMSO‑d₆, 400 MHz) distinguishes the two isomers unequivocally: the C‑5 proton of the 4‑carboxylate appears as a sharp singlet at δ 7.62 ppm, while the C‑4 proton of the 5‑regioisomer resonates at δ 7.48 ppm. The integration ratio of these signals serves as the release criterion; a specification limit of not more than 0.5% 5‑carboxylate relative to the main peak is enforced.

    The presence of the positional isomer above this threshold has been correlated with a gene‑tox alert in the Ames II test (TA98 and TA100 strains) for the final active pharmaceutical ingredient because the 5‑carboxylate scaffold appears in a hydrazine‑forming fragment upon metabolic activation. Consequently, the purification protocol following the cyclization step includes a charcoal treatment at 70 °C for 45 minutes followed by a seeded crystallization from isopropanol/water, which preferentially rejects the 5‑carboxylate into the mother liquor.

    For large‑scale users evaluating a supplier change, the differential scanning calorimetry trace offers a rapid identity check: the methyl ester melts with a sharp endotherm at 167.5 °C (onset), whereas the 5‑carboxylate homologue melts at 183.2 °C. A dual‑peak thermogram immediately signals a contamination event and precludes charging the lot before confirmatory HPLC analysis.

    Process Mass Intensity and Solvent Recovery in Multi‑Ton Campaigns

    Process mass intensity (PMI) benchmarks for the conversion of methyl 2‑aminothiazole‑4‑carboxylate into the corresponding carboxamide average 18.3 kg total input per 1 kg of isolated product when starting from the commercial ester of 99.5% purity. The largest contributing factor is the methanol/water solvent system, which accounts for 12.1 kg. In‑situ recovery of methanol during the vacuum distillation of ammonia raises the recycling efficiency to 82%, dropping the net fresh‑solvent demand to 2.2 kg/kg product. Facilities configured with thin‑film evaporators report batch‑to‑batch methanol recovery yields exceeding 90% when the evaporator jacket is held at 45 °C with a condensate temperature of −5 °C. The recovered methanol contains 0.2–0.5% water and must be dried over 3Å molecular sieves before re‑use in a water‑sensitive subsequent step.

    Comparison with ethyl 2‑aminothiazole‑4‑carboxylate is instructive here: the ethyl ester’s higher boiling matrix solvents (ethanol/ethyl acetate) lead to a PMI of 22.4 kg/kg under analogous conditions, largely due to less efficient recovery from aqueous quenches. The methyl ester therefore becomes the default choice for kilo‑lab to pilot‑plant campaigns that have been optimized for low solvent inventory.

    Avoiding Oxidative Dimerization During Storage of Subdivided Batches

    When the bulk powder is subdivided into low‑density polyethylene liners for dispensing to multiple production suites, the surface area increases by approximately 30‑fold relative to the fibre‑drum configuration. Oxidative coupling of the primary amine, catalyzed by residual copper ions from the manufacturing equipment, accelerates in the subdivided state. Specification of copper content is set at ≤10 ppm, determined by atomic absorption spectroscopy. Batches exceeding this threshold are quenched with ethylenediaminetetraacetic acid disodium salt (0.01 wt%) blended into the powder, which chelates the copper and halts the formation of the dimeric azobenzimidazole derivative. This treatment has no impact on subsequent amidation yields, provided the sequestering agent is removed during the aqueous work‑up.

    When the material is used directly in a Buchwald‑Hartwig coupling as the amine partner, the substrate is often pre‑complexed with XPhos Pd G3 in degassed 2‑methyltetrahydrofuran. In this configuration, any residual oxygen in the solvent generates a persistent blue‑green coloration indicative of Pd(II) reduction that competes with the desired catalytic cycle. Sparging the mixture with nitrogen until the dissolved oxygen falls below 0.5 ppm (measured with an optical probe) is mandatory; otherwise, turnover numbers drop from a typical 5000 to below 800.

    Key Operational Boundaries for Methyl 2‑Aminothiazole‑4‑carboxylate in Downstream Chemistry
    OperationCritical ParameterPermissible RangeConsequence of Deviation
    Amidation with NH₃/MeOHWater content of ester charge (KF)≤0.3%Yield loss to carboxylic acid; extended cycle time
    Amidation with NH₃/MeOHReactor jacket temperature during pre‑drying50–60 °CSintering of powder above 65 °C
    Acylation of 2‑NH₂pH of bicarbonate scrub8.0–8.3Ring chlorination at C‑5 >1%
    Lithium hydroxide hydrolysisReaction temperature0–5 °CDecarboxylation of the free acid above 40 °C
    Storage of subdivided powderCopper content≤10 ppmOxidative dimerization; discoloration; loss of potency
    Buchwald‑Hartwig couplingDissolved oxygen in 2‑MeTHF<0.5 ppmTurnover number collapse by ~84%

    In installations where the ester is telescoped without isolation into a mixed‑anhydride activation regime, the intermediate chloroformate generated from isobutyl chloroformate and N‑methylmorpholine at −20 °C shows a half‑life of less than 20 minutes at that temperature. The flow stream must therefore be fed continuously into the nucleophile solution within a residence time of <12 minutes to avoid decomposition to an unreactive urea side product. This flow approach has been validated on a Corning® Advanced‑Flow™ G1 reactor with a total internal volume of 8.2 mL, achieving a throughput of 45 g/h of activated ester.

    Published data for the direct conversion of methyl 2‑aminothiazole‑4‑carboxylate into the hydrazide derivative using hydrazine hydrate in ethanol at reflux is limited; however, plant‑scale observations indicate that the reaction mixture must be kept anhydrous with molecular sieves present, as the hydrazinolysis rate is severely retarded by even 2% water. The competing hydrolysis regenerates the carboxylate, which precipitates as the hydrazinium salt and becomes difficult to re‑dissolve without adding methanesulfonic acid, a practice incompatible with subsequent crystallizations in highly regulated environments.